Company intelligence / Profile preview

ReShape Lifesciences

Irvine, California, United Statesreshapelifesciences.com ↗
Ownership
Public · RSLS
Development stage
Commercial
01

Overview

ReShape Lifesciences has commercialized minimally invasive weight-loss devices such as the FDA-approved Lap-Band®, the non-surgical Obalon® Gastric Balloon system, and offers a virtual health coaching program. The company also developed an investigational vagal neuromodulation technology for type 2 diabetes that has completed preclinical development with strong IP protection through at least the late 2030s. In Q2/Q3 of calendar year 2025, ReShape entered into a definitive merger agreement with Vyome Therapeutics and agreed to sell substantially all its assets—including its core products—to Biorad Medisys. After these transactions close, the combined entity will be renamed Vyome Holdings.

Therapeutic areas
EndocrinologyCardiovascularMetabolic Disorders
Modalities
DeviceNeuromodulation deviceBalloon deviceVirtual health coaching program
Industry
Therapeutic Medical Devices
02

Drug pipeline

3 assets

Lap-Band System

Commercial
Indications
Obesity

2 more assets in the full pipeline.

Request access →
03

Partnerships

Distribution agreements with Liaison Medical and Recon Supply for VA/DoD markets in North America.Exclusive license agreement previously with Biorad Medisys for certain technologies.
04

Financials

Market cap
$2.3M
Total revenue
$27K
Enterprise value
$-5.5M

Beyond the preview

Go deeper on ReShape Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReShape Lifesciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call